NLS Pharmaceutics (NLSP)
NASDAQ:NLSP
US Market
Holding NLSP?
Track your performance easily

NLS Pharmaceutics (NLSP) Financial Statements

198 Followers

NLS Pharmaceutics Financial Overview

NLS Pharmaceutics's market cap is currently ―. The company's EPS TTM is $-0.189; its P/E ratio is -20.62; NLS Pharmaceutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Jun 22Dec 21Jun 21
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 908.34K$ 8.95M$ 1.35M$ 5.43M$ 7.09M
Total Assets$ 1.85M$ 9.28M$ 2.06M$ 5.76M$ 8.27M
Total Debt$ 1.66M$ 0.00$ 354.34K$ 0.00$ 0.00
Net Debt$ 751.01K$ -8.95M$ -999.85K$ -5.43M$ -7.09M
Total Liabilities$ 10.68M$ 6.00M$ 6.10M$ 5.22M$ 4.02M
Stockholders Equity$ -8.83M$ 3.28M$ -4.04M$ 542.39K$ 4.25M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

NLS Pharmaceutics Earnings and Revenue History

NLS Pharmaceutics Debt to Assets

NLS Pharmaceutics Cash Flow

NLS Pharmaceutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis